| Trial ID: | L0014 |
| Source ID: | NCT02491905
|
| Associated Drug: |
HL Tablet
|
| Title: |
Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: HL tablet|Drug: Placebo
|
| Outcome Measures: |
To assess the change of hepatic fat by Magnetic Resonance spectroscopy (MRS) after administration of HL tablet compared with baseline|Changes in Alanine Transaminase (ALT)|Changes in Asparate Transaminase (AST)|Changes in cholesterol|Changes in triglyceride|Changes in free fatty acid|Changes in insulin resistance|Changes in Body Mass Index (BMI)
|
| Sponsor/Collaborators: |
Huons Co., Ltd.
|
| Gender: |
All
|
| Age: |
19 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
69
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
November 2013
|
| Completion Date: |
May 2015
|
| Results First Posted: |
--
|
| Last Update Posted: |
July 8, 2015
|
| Locations: |
Huons, Ansan, Kyeonggi-do, Korea, Republic of
|
| URL: |
https://ClinicalTrials.gov/show/NCT02491905
|
